Skip to main content
Veterinary Medicines

Rabisin suspension injectable

Authorised
  • Rabies virus, Inactivated

Product identification

Medicine name:
Rabisin suspension injectable
Rabisin injektionssuspension
Active substance:
  • Rabies virus, Inactivated
Target species:
  • Sheep
  • Cattle
  • Horse
  • Cat
  • Dog
  • Mustelids
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, Inactivated
    1.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
      • Meat and offal, milk
        0
        day
    • Cattle
      • Meat and offal, milk
        0
        day
    • Horse
      • Meat and offal, milk
        0
        day
    • Cat
    • Dog
    • Mustelids
  • Subcutaneous use
    • Sheep
      • Meat and offal, milk
        0
        day
    • Cattle
      • Meat and offal, milk
        0
        day
    • Cat
    • Dog
    • Mustelids
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Available in:
  • Luxembourg
Package description:
  • Rabisin 10 Vials x 1ml Suspension for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 344/86/12/0337
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/03/2023

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/03/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."